Around the Practice: ctDNA in Treatment Decisions and Monitoring

Centering discussion on patient scenarios, expert oncologists define the current and future use of MRD and ctDNA in both colorectal and breast cancer management.

EP. 1: Scenario 1: ctDNA to Determine Use of Adjuvant Chemotherapy in Stage II CRC

July 28th 2022

Centering discussion on a patient scenario of stage II colorectal cancer, expert oncologists consider how ctDNA may inform use of adjuvant chemotherapy in this setting.

EP. 2: Future Role of ctDNA in CRC: Surveillance and Treatment Selection

July 28th 2022

Shared insight on the potential roles of ctDNA and MRD testing in the monitoring and treatment of patients with colorectal cancer.

EP. 3: Understanding the Mechanisms and Use of ctDNA and MRD Testing

August 4th 2022

Expert panelists elucidate the mechanisms of ctDNA and MRD testing, providing a broad perspective on how they are used in cancer care.

EP. 4: Identifying Use of ctDNA Across Tumor Types

August 4th 2022

Focusing on breast cancer, lung cancer, and GI cancers respectively, expert oncologists review the utility of circulating tumor DNA assays.